| Harmonised Commodity Description and Coding System (HS) - level 2 - Chapter |
30 |
Pharmaceutical products |
| Harmonised Commodity Description and Coding System (HS) - level 4 - Article |
300212 |
Antisera and other blood fractions |
| Harmonised Commodity Description and Coding System (HS) - level 4 - Article |
300213 |
Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale (excl. diagnostic reagents) |
| Harmonised Commodity Description and Coding System (HS) - level 4 - Article |
300214 |
Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale (excl. diagnostic reagents) |
| Harmonised Commodity Description and Coding System (HS) - level 4 - Article |
300215 |
Immunological products, put up in measured doses or in forms or packings for retail sale (excl. diagnostic reagents) |
| Harmonised Commodity Description and Coding System (HS) - level 4 - Article |
300241 |
Vaccines for human medicine |
| Harmonised Commodity Description and Coding System (HS) - level 4 - Article |
300242 |
Vaccines for veterinary medicine |
| Harmonised Commodity Description and Coding System (HS) - level 4 - Article |
300249 |
Toxins, cultures of micro-organisms and similar products, e.g. plasmodia (excl. yeasts and vaccines) |
| Harmonised Commodity Description and Coding System (HS) - level 4 - Article |
300251 |
Cell therapy products |
| Harmonised Commodity Description and Coding System (HS) - level 4 - Article |
300259 |
Cell cultures, whether or not modified (excl. cell therapy products) |
| Harmonised Commodity Description and Coding System (HS) - level 4 - Article |
300290 |
Human blood, animal blood prepared for therapeutic, prophylactic or diagnostic uses |
Statistical metainformation system
